CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2022 / 01:15PM GMT
Release Date Price: R$59.2 (-0.18%)
Lisa Christine Gill
JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst

Good morning, and welcome to day 2 of JPMorgan's Virtual Healthcare Conference. My name is Lisa Gill, and I'm the health care services analyst with JPMorgan. This morning, it is with great pleasure that I have CVS Health, one of the largest diversified health care services companies in the U.S. With us today, we have CEO, Karen Lynch; as well as CFO, Shawn Guertin. They're going to run through our presentation, and then we'll have a fireside chat. So with that, let me talk it over to Karen. Good morning, Karen.

Karen Sue Lynch
CVS Health Corporation - President, CEO & Director

Hi, Lisa, good morning, and thanks, everyone, for joining us. Today, I'm going to spend some time providing you with a brief update on our 2021 results. And then, as you know, we just had our Investor Day, Lisa, in December. So I'll recap our -- a little bit about our Investor Day and talk about some of the bold moves

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot